0.017094
0.000000
0.000000
0.000000
0.011338
0.000000
0.000000
0.000000
0.010616
0.00000
0.00000
0.00000
Hong, L.
Zhang, X.-J.
Foundling, S.
Hartsuck, J.A.
Tang, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
16
90.00
90.00
90.00
58.500
88.200
94.200
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C28 H52 N8 O6
596.762
N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE
non-polymer
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
FEBS Lett.
FEBLAL
0165
0014-5793
420
11
16
10.1016/S0014-5793(97)01477-4
9450540
Structure of a G48H mutant of HIV-1 protease explains how glycine-48 replacements produce mutants resistant to inhibitor drugs.
1997
10.2210/pdb1a9m/pdb
pdb_00001a9m
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
293
1
AREA DETECTOR
1996-04
SIEMENS
NI FILTER
M
x-ray
1
1.5418
1.0
1.5418
10884.852
HIV-1 PROTEASE
G48H
2
man
polymer
596.762
N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE
1
syn
non-polymer
18.015
water
59
nat
water
no
no
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIHGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIHGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT
PVNIIGRNLLTQIGCTLNF
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Lentivirus
Escherichia
Escherichia coli
sample
11676
Human immunodeficiency virus 1
511693
Escherichia coli BL21
BL21
PET3B
1
2.8
55.90
VAPOR DIFFUSION
6.8
THE PROTEIN SOLUTION CONTAINED 6.5 MG/ML MUTANT HIV-1 PROTEASE IN 20 MM SODIUM ACETATE, 1 MM DITHIOTHREITOL, PH 5.5, WITH A 10-FOLD MOLAR EXCESS OF INHIBITOR. THE RESERVOIR SOLUTIONS FOR THE VAPOR DIFFUSION CONTAINED 10% DIMETHYLSULFOXIDE, 30 MM B-MERCAPTOETHANOL AND 4% 2-PROPANOL IN ADDITION TO THE PRECIPITANT. THE MOST FAVORABLE CRYSTALLIZATION CONDITIONS WERE 42% SATURATED AMMONIUM SULFATE, PH 6.8., vapor diffusion
5.5-6.8
database_2
pdbx_database_status
struct_ref_seq_dif
struct_site
pdbx_initial_refinement_model
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
Refinement description
1
0
1998-06-17
1
1
2008-03-03
1
2
2011-07-13
1
3
2021-11-03
1
4
2023-08-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
Y
BNL
1998-04-08
REL
U0E
N-[[1-[N-ACETAMIDYL]-[1-CYCLOHEXYLMETHYL-2-HYDROXY-4-ISOPROPYL]-BUT-4-YL]-CARBONYL]-GLUTAMINYL-ARGINYL-AMIDE
HOH
water
1GNO
PDB ENTRY 1GNO
PDB
experimental model
U0E
1
2
U0E
U0E
100
B
HOH
3
3
HOH
HOH
100
A
HOH
4
3
HOH
HOH
101
A
HOH
7
3
HOH
HOH
102
A
HOH
8
3
HOH
HOH
103
A
HOH
9
3
HOH
HOH
104
A
HOH
11
3
HOH
HOH
105
A
HOH
12
3
HOH
HOH
106
A
HOH
13
3
HOH
HOH
107
A
HOH
14
3
HOH
HOH
108
A
HOH
19
3
HOH
HOH
109
A
HOH
22
3
HOH
HOH
110
A
HOH
23
3
HOH
HOH
111
A
HOH
25
3
HOH
HOH
112
A
HOH
31
3
HOH
HOH
113
A
HOH
33
3
HOH
HOH
114
A
HOH
34
3
HOH
HOH
115
A
HOH
38
3
HOH
HOH
116
A
HOH
43
3
HOH
HOH
117
A
HOH
44
3
HOH
HOH
118
A
HOH
52
3
HOH
HOH
119
A
HOH
53
3
HOH
HOH
120
A
HOH
55
3
HOH
HOH
121
A
HOH
56
3
HOH
HOH
122
A
HOH
57
3
HOH
HOH
123
A
HOH
58
3
HOH
HOH
124
A
HOH
59
3
HOH
HOH
125
A
HOH
1
3
HOH
HOH
101
B
HOH
2
3
HOH
HOH
102
B
HOH
5
3
HOH
HOH
103
B
HOH
6
3
HOH
HOH
104
B
HOH
10
3
HOH
HOH
105
B
HOH
15
3
HOH
HOH
106
B
HOH
16
3
HOH
HOH
107
B
HOH
17
3
HOH
HOH
108
B
HOH
18
3
HOH
HOH
109
B
HOH
20
3
HOH
HOH
110
B
HOH
21
3
HOH
HOH
111
B
HOH
24
3
HOH
HOH
112
B
HOH
26
3
HOH
HOH
113
B
HOH
27
3
HOH
HOH
114
B
HOH
28
3
HOH
HOH
115
B
HOH
29
3
HOH
HOH
116
B
HOH
30
3
HOH
HOH
117
B
HOH
32
3
HOH
HOH
118
B
HOH
35
3
HOH
HOH
119
B
HOH
36
3
HOH
HOH
120
B
HOH
37
3
HOH
HOH
121
B
HOH
39
3
HOH
HOH
122
B
HOH
40
3
HOH
HOH
123
B
HOH
41
3
HOH
HOH
124
B
HOH
42
3
HOH
HOH
125
B
HOH
45
3
HOH
HOH
126
B
HOH
46
3
HOH
HOH
127
B
HOH
47
3
HOH
HOH
128
B
HOH
48
3
HOH
HOH
129
B
HOH
49
3
HOH
HOH
130
B
HOH
50
3
HOH
HOH
131
B
HOH
51
3
HOH
HOH
132
B
HOH
54
3
HOH
HOH
133
B
PRO
1
n
1
PRO
1
A
GLN
2
n
2
GLN
2
A
ILE
3
n
3
ILE
3
A
THR
4
n
4
THR
4
A
LEU
5
n
5
LEU
5
A
TRP
6
n
6
TRP
6
A
GLN
7
n
7
GLN
7
A
ARG
8
n
8
ARG
8
A
PRO
9
n
9
PRO
9
A
LEU
10
n
10
LEU
10
A
VAL
11
n
11
VAL
11
A
THR
12
n
12
THR
12
A
ILE
13
n
13
ILE
13
A
LYS
14
n
14
LYS
14
A
ILE
15
n
15
ILE
15
A
GLY
16
n
16
GLY
16
A
GLY
17
n
17
GLY
17
A
GLN
18
n
18
GLN
18
A
LEU
19
n
19
LEU
19
A
LYS
20
n
20
LYS
20
A
GLU
21
n
21
GLU
21
A
ALA
22
n
22
ALA
22
A
LEU
23
n
23
LEU
23
A
LEU
24
n
24
LEU
24
A
ASP
25
n
25
ASP
25
A
THR
26
n
26
THR
26
A
GLY
27
n
27
GLY
27
A
ALA
28
n
28
ALA
28
A
ASP
29
n
29
ASP
29
A
ASP
30
n
30
ASP
30
A
THR
31
n
31
THR
31
A
VAL
32
n
32
VAL
32
A
LEU
33
n
33
LEU
33
A
GLU
34
n
34
GLU
34
A
GLU
35
n
35
GLU
35
A
MET
36
n
36
MET
36
A
SER
37
n
37
SER
37
A
LEU
38
n
38
LEU
38
A
PRO
39
n
39
PRO
39
A
GLY
40
n
40
GLY
40
A
ARG
41
n
41
ARG
41
A
TRP
42
n
42
TRP
42
A
LYS
43
n
43
LYS
43
A
PRO
44
n
44
PRO
44
A
LYS
45
n
45
LYS
45
A
MET
46
n
46
MET
46
A
ILE
47
n
47
ILE
47
A
HIS
48
n
48
HIS
48
A
GLY
49
n
49
GLY
49
A
ILE
50
n
50
ILE
50
A
GLY
51
n
51
GLY
51
A
GLY
52
n
52
GLY
52
A
PHE
53
n
53
PHE
53
A
ILE
54
n
54
ILE
54
A
LYS
55
n
55
LYS
55
A
VAL
56
n
56
VAL
56
A
ARG
57
n
57
ARG
57
A
GLN
58
n
58
GLN
58
A
TYR
59
n
59
TYR
59
A
ASP
60
n
60
ASP
60
A
GLN
61
n
61
GLN
61
A
ILE
62
n
62
ILE
62
A
LEU
63
n
63
LEU
63
A
ILE
64
n
64
ILE
64
A
GLU
65
n
65
GLU
65
A
ILE
66
n
66
ILE
66
A
CYS
67
n
67
CYS
67
A
GLY
68
n
68
GLY
68
A
HIS
69
n
69
HIS
69
A
LYS
70
n
70
LYS
70
A
ALA
71
n
71
ALA
71
A
ILE
72
n
72
ILE
72
A
GLY
73
n
73
GLY
73
A
THR
74
n
74
THR
74
A
VAL
75
n
75
VAL
75
A
LEU
76
n
76
LEU
76
A
VAL
77
n
77
VAL
77
A
GLY
78
n
78
GLY
78
A
PRO
79
n
79
PRO
79
A
THR
80
n
80
THR
80
A
PRO
81
n
81
PRO
81
A
VAL
82
n
82
VAL
82
A
ASN
83
n
83
ASN
83
A
ILE
84
n
84
ILE
84
A
ILE
85
n
85
ILE
85
A
GLY
86
n
86
GLY
86
A
ARG
87
n
87
ARG
87
A
ASN
88
n
88
ASN
88
A
LEU
89
n
89
LEU
89
A
LEU
90
n
90
LEU
90
A
THR
91
n
91
THR
91
A
GLN
92
n
92
GLN
92
A
ILE
93
n
93
ILE
93
A
GLY
94
n
94
GLY
94
A
CYS
95
n
95
CYS
95
A
THR
96
n
96
THR
96
A
LEU
97
n
97
LEU
97
A
ASN
98
n
98
ASN
98
A
PHE
99
n
99
PHE
99
A
PRO
1
n
1
PRO
1
B
GLN
2
n
2
GLN
2
B
ILE
3
n
3
ILE
3
B
THR
4
n
4
THR
4
B
LEU
5
n
5
LEU
5
B
TRP
6
n
6
TRP
6
B
GLN
7
n
7
GLN
7
B
ARG
8
n
8
ARG
8
B
PRO
9
n
9
PRO
9
B
LEU
10
n
10
LEU
10
B
VAL
11
n
11
VAL
11
B
THR
12
n
12
THR
12
B
ILE
13
n
13
ILE
13
B
LYS
14
n
14
LYS
14
B
ILE
15
n
15
ILE
15
B
GLY
16
n
16
GLY
16
B
GLY
17
n
17
GLY
17
B
GLN
18
n
18
GLN
18
B
LEU
19
n
19
LEU
19
B
LYS
20
n
20
LYS
20
B
GLU
21
n
21
GLU
21
B
ALA
22
n
22
ALA
22
B
LEU
23
n
23
LEU
23
B
LEU
24
n
24
LEU
24
B
ASP
25
n
25
ASP
25
B
THR
26
n
26
THR
26
B
GLY
27
n
27
GLY
27
B
ALA
28
n
28
ALA
28
B
ASP
29
n
29
ASP
29
B
ASP
30
n
30
ASP
30
B
THR
31
n
31
THR
31
B
VAL
32
n
32
VAL
32
B
LEU
33
n
33
LEU
33
B
GLU
34
n
34
GLU
34
B
GLU
35
n
35
GLU
35
B
MET
36
n
36
MET
36
B
SER
37
n
37
SER
37
B
LEU
38
n
38
LEU
38
B
PRO
39
n
39
PRO
39
B
GLY
40
n
40
GLY
40
B
ARG
41
n
41
ARG
41
B
TRP
42
n
42
TRP
42
B
LYS
43
n
43
LYS
43
B
PRO
44
n
44
PRO
44
B
LYS
45
n
45
LYS
45
B
MET
46
n
46
MET
46
B
ILE
47
n
47
ILE
47
B
HIS
48
n
48
HIS
48
B
GLY
49
n
49
GLY
49
B
ILE
50
n
50
ILE
50
B
GLY
51
n
51
GLY
51
B
GLY
52
n
52
GLY
52
B
PHE
53
n
53
PHE
53
B
ILE
54
n
54
ILE
54
B
LYS
55
n
55
LYS
55
B
VAL
56
n
56
VAL
56
B
ARG
57
n
57
ARG
57
B
GLN
58
n
58
GLN
58
B
TYR
59
n
59
TYR
59
B
ASP
60
n
60
ASP
60
B
GLN
61
n
61
GLN
61
B
ILE
62
n
62
ILE
62
B
LEU
63
n
63
LEU
63
B
ILE
64
n
64
ILE
64
B
GLU
65
n
65
GLU
65
B
ILE
66
n
66
ILE
66
B
CYS
67
n
67
CYS
67
B
GLY
68
n
68
GLY
68
B
HIS
69
n
69
HIS
69
B
LYS
70
n
70
LYS
70
B
ALA
71
n
71
ALA
71
B
ILE
72
n
72
ILE
72
B
GLY
73
n
73
GLY
73
B
THR
74
n
74
THR
74
B
VAL
75
n
75
VAL
75
B
LEU
76
n
76
LEU
76
B
VAL
77
n
77
VAL
77
B
GLY
78
n
78
GLY
78
B
PRO
79
n
79
PRO
79
B
THR
80
n
80
THR
80
B
PRO
81
n
81
PRO
81
B
VAL
82
n
82
VAL
82
B
ASN
83
n
83
ASN
83
B
ILE
84
n
84
ILE
84
B
ILE
85
n
85
ILE
85
B
GLY
86
n
86
GLY
86
B
ARG
87
n
87
ARG
87
B
ASN
88
n
88
ASN
88
B
LEU
89
n
89
LEU
89
B
LEU
90
n
90
LEU
90
B
THR
91
n
91
THR
91
B
GLN
92
n
92
GLN
92
B
ILE
93
n
93
ILE
93
B
GLY
94
n
94
GLY
94
B
CYS
95
n
95
CYS
95
B
THR
96
n
96
THR
96
B
LEU
97
n
97
LEU
97
B
ASN
98
n
98
ASN
98
B
PHE
99
n
99
PHE
99
B
author_and_software_defined_assembly
PISA
2
dimeric
5230
-17
9130
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
HIS
69
A
O
HIS
69
A
N
ILE
66
A
N
ILE
66
A
O
GLU
65
A
O
GLU
65
A
N
LYS
14
A
N
LYS
14
A
O
VAL
11
A
O
VAL
11
A
N
ALA
22
A
N
ALA
22
A
O
LEU
23
A
O
LEU
23
A
N
ASN
83
A
N
ASN
83
A
O
LYS
43
A
O
LYS
43
A
N
GLN
58
A
N
GLN
58
A
O
ARG
57
A
O
ARG
57
A
N
VAL
77
A
N
VAL
77
B
O
GLN
18
B
O
GLN
18
B
N
ILE
15
B
N
ILE
15
B
O
LYS
14
B
O
LYS
14
B
N
GLU
65
B
N
GLU
65
B
O
ILE
62
B
O
ILE
62
B
N
GLY
73
B
N
GLY
73
B
O
LEU
33
B
O
LEU
33
B
N
LEU
76
B
N
LEU
76
B
O
VAL
75
B
O
VAL
75
B
N
TYR
59
B
N
TYR
59
B
O
ILE
54
B
O
ILE
54
B
N
ILE
47
B
N
ILE
47
1
-12.23
1.90
111.40
99.17
A
A
A
CB
CA
C
VAL
VAL
VAL
82
82
82
N
1
A
PRO
39
-70.53
35.33
1
A
CYS
67
37.44
56.74
1
B
PRO
9
-69.91
76.03
1
B
CYS
67
33.29
55.12
1
B
PRO
79
-71.73
42.91
PARHCSDX.PRO
TOPHCSDX.PRO
INHPAR.PRO
INHTOP.PRO
36.6
0.1850000
0.1850000
2.3
8.
8697
78.
1
MOLECULAR REPLACEMENT
PDB ENTRY 1GNO
2.3
8.
59
1629
42
0
1528
0.013
1.8
28.5
1.7
37.0
2.3
100.
1A9M
8697
0.0730000
1
15.
3.0
78.
2.3
2.42
3.
0.3200000
2.
52.6
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
data reduction
SAINT
data scaling
SAINT
phasing
X-PLOR
3.1
G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E
1
N
N
1
N
N
2
N
N
3
N
N
3
N
N
A
ARG
87
A
ARG
87
HELX_P
A
ILE
93
A
ILE
93
1
1
7
B
ARG
87
B
ARG
87
HELX_P
B
LEU
90
B
LEU
90
1
2
4
ASPARTYL PROTEASE
ASPARTYL PROTEASE, DRUG RESISTANT, MUTATION
given
-0.417150
-0.748410
0.515620
-0.740240
-0.049360
-0.670530
0.527280
-0.661390
-0.533410
42.53785
96.42136
89.95747
POL_HV1PV
UNP
1
1
P03368
FFREDLAFLQGKAREFSSEQTRANSPTISSEQTRANSPTRRELQVWGRDNNSPSEAGADRQGTVSFNFPQITLWQRPLVT
IKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQ
IGCTLNFPISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRK
LVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGW
KGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYE
LHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEP
VHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPI
QKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRETRLGKAGYLTNKGRQKVVPLTNTT
NQKTELQAIYLALQDSGLEVNIVTDSQYALGIIQAQPDQSESELVNQIIEQLIKKQKVYLAWVPAHKGIGGNEQVDKLVS
AGIRKILFLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVI
LVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSATVKAACWWAGIKQEFGIPYNPQSQGVVES
MNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNP
LWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED
69
167
1A9M
1
99
P03368
A
1
1
99
69
167
1A9M
1
99
P03368
B
1
1
99
1
GLY
engineered mutation
HIS
48
1A9M
A
P03368
UNP
116
48
2
GLY
engineered mutation
HIS
48
1A9M
B
P03368
UNP
116
48
5
3
4
4
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
A
HIS
69
A
HIS
69
A
GLY
73
A
GLY
73
A
ILE
62
A
ILE
62
A
ILE
66
A
ILE
66
A
LEU
10
A
LEU
10
A
ILE
15
A
ILE
15
A
GLN
18
A
GLN
18
A
LEU
24
A
LEU
24
A
ASN
83
A
ASN
83
A
ILE
85
A
ILE
85
A
LYS
43
A
LYS
43
A
HIS
48
A
HIS
48
A
PHE
53
A
PHE
53
A
TYR
59
A
TYR
59
A
VAL
75
A
VAL
75
A
VAL
77
A
VAL
77
B
GLN
18
B
GLN
18
B
LEU
23
B
LEU
23
B
LEU
10
B
LEU
10
B
ILE
15
B
ILE
15
B
ILE
62
B
ILE
62
B
ILE
66
B
ILE
66
B
HIS
69
B
HIS
69
B
GLY
73
B
GLY
73
B
VAL
32
B
VAL
32
B
GLU
34
B
GLU
34
B
VAL
75
B
VAL
75
B
GLY
78
B
GLY
78
B
PHE
53
B
PHE
53
B
TYR
59
B
TYR
59
B
LYS
43
B
LYS
43
B
HIS
48
B
HIS
48
BINDING SITE FOR RESIDUE U0E B 100
B
U0E
100
Software
18
A
ARG
8
A
ARG
8
18
1_555
A
ASP
25
A
ASP
25
18
1_555
A
GLY
27
A
GLY
27
18
1_555
A
GLY
49
A
GLY
49
18
1_555
A
VAL
82
A
VAL
82
18
1_555
A
ILE
84
A
ILE
84
18
1_555
A
HOH
102
D
HOH
18
1_555
B
LEU
23
B
LEU
23
18
1_555
B
ASP
25
B
ASP
25
18
1_555
B
GLY
27
B
GLY
27
18
1_555
B
ALA
28
B
ALA
28
18
1_555
B
ASP
29
B
ASP
29
18
1_555
B
ASP
30
B
ASP
30
18
1_555
B
ILE
47
B
ILE
47
18
1_555
B
HIS
48
B
HIS
48
18
1_555
B
GLY
49
B
GLY
49
18
1_555
B
ILE
50
B
ILE
50
18
1_555
B
VAL
82
B
VAL
82
18
1_555
23
I 2 2 2